Major histocompatibility complex–T cell receptor complex (MHC–TCR complex)

The MHC–TCR complex refers to the transient, highly specific interaction between a peptide-loaded major histocompatibility complex molecule (presenting cell) and a T cell receptor (T cell), essential for antigen recognition and initiation of adaptive immune responses. The MHC provides a platform for displaying processed peptide antigens, while the TCR scans these complexes, initiating intracellular signaling only when a proper match is sensed. This interaction underpins T cell activation, memory, and tolerance. Aberrations in MHC–TCR engagement underlie a wide spectrum of immune pathologies, and the interface is central to the mechanisms of cellular immunotherapies and vaccine design. Note: "MHC–TCR complex" should not be used as a canonical molecular target. Instead, structured data should separately represent MHC (including the specific allele or class, e.g., "HLA-B27", "Major histocompatibility complex class I"), TCR (e.g., "T cell receptor alpha chain", "T cell receptor beta chain"), or their recombinant interaction when relevant.

Other names

MHC–TCR interfaceMHC-antigen–TCR complexPeptide–MHC–TCR interactionpMHC–TCR complex (where "pMHC" refers to peptide–MHC complex)

Immune checkpoint inhibitors: Block inhibitory receptors (e.g., PD-1, CTLA-4) downstream of MHC/TCR to restore T cell activation Adoptive cell therapy: Use of TCR-engineered T cells or CAR-T cells to enhance recognition of specific pMHC complexes Peptide vaccines: Aim to optimize peptide–MHC presentation to TCRs for targeted activation